<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00913185</url>
  </required_header>
  <id_info>
    <org_study_id>1021</org_study_id>
    <nct_id>NCT00913185</nct_id>
    <nct_alias>NCT00419523</nct_alias>
  </id_info>
  <brief_title>Comparison Study of Topical Acne Regimens</brief_title>
  <official_title>Acne Free vs. Proactiv for the Treatment of Moderately Severe Acne Vulgaris</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>MedDerm Associates</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>MedDerm Associates</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the effectiveness of two over the counter acne&#xD;
      products in subjects with moderate severity acne vulgaris. The two products being compared in&#xD;
      this study are Acne Free &quot;Severe Acne Line&quot; manufactured by University Medical Products, and&#xD;
      ProactivÂ® manufactured by Guthy-Renker.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      You will receive a study drug for the 8 week study. No subject will be given a placebo (an&#xD;
      inactive substance) during treatment.The study drugs (over the counter acne medications) have&#xD;
      been previously tested and their safe use has been established. However, not all risks or&#xD;
      side effects are known. In rare cases of allergy, side effects may be life threatening.The&#xD;
      most common side effects of this study drug are:&#xD;
&#xD;
        1. Dry skin&#xD;
&#xD;
        2. Peeling skin&#xD;
&#xD;
        3. Red skin&#xD;
&#xD;
        4. Burning or tingling (temporary)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2006</start_date>
  <completion_date type="Actual">February 2008</completion_date>
  <primary_completion_date type="Actual">December 2006</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <enrollment type="Anticipated">128</enrollment>
  <condition>Acne</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acne Free, Proactiv</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subjects and/or subjects' legal guardians who understand and are willing to sign an&#xD;
             Informed Consent Form, an Assent Form if indicated, and a HIPAA Authorization Form.&#xD;
&#xD;
          -  Subjects who have received the permission of a parent or guardian to participate in&#xD;
             this study or cannot be classified as a minor, under the age of 18 years.&#xD;
&#xD;
          -  Male and female subjects between the ages of 13 and 45 years and in generally good&#xD;
             health, as determined by a Medical History Form.&#xD;
&#xD;
          -  Subjects with moderately-severe acne vulgaris of the face and neck as determined and&#xD;
             defined by baseline lesion counts (see Definition: Acne Severity above).&#xD;
&#xD;
          -  Subjects who have completed a Medical History Form.&#xD;
&#xD;
          -  Subjects who have not used oral acne medications for 1 month prior to start of study,&#xD;
             and topical acne medications 1 week prior to start of study.&#xD;
&#xD;
          -  Subjects who agree not to use any acne medication during the study except for the test&#xD;
             materials given to them.&#xD;
&#xD;
          -  Subjects who agree not to use any make-up that contains acne treatment additives, such&#xD;
             as benzoyl peroxide, salicylic acid or retinol.&#xD;
&#xD;
          -  Subjects who are willing to be photographed and video-recorded during study visits and&#xD;
             willing to sign photographic release forms.&#xD;
&#xD;
          -  Subjects who exhibit dependability and intelligence in following directions.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subjects who are pregnant or lactating.&#xD;
&#xD;
          -  Subjects with known allergies to cosmetic, toiletry, or acne treatment products.&#xD;
&#xD;
          -  Subjects who are sensitive to any of the ingredients in the test articles.&#xD;
&#xD;
          -  Subjects who have participated in a facial treatment study within 3 weeks of study&#xD;
             initiation.&#xD;
&#xD;
          -  Subjects exhibiting acute or chronic dermatological, medical, and/or physical&#xD;
             conditions which would preclude application of the test materials and/or influence the&#xD;
             outcome of the study.&#xD;
&#xD;
          -  Subjects who are unable to sit quietly for 15 minutes to acclimate to ambient&#xD;
             temperature and humidity conditions in the laboratory.&#xD;
&#xD;
          -  Male subjects who do not have a full beard.&#xD;
&#xD;
          -  Subjects who cannot stop usage of oral acne mediation 1 month prior to study start,&#xD;
             and topical acne medications 1 week prior to study start.&#xD;
&#xD;
          -  Subjects taking routine high dosage anti-inflammatory medications (aspirin,&#xD;
             ibuprofen).&#xD;
&#xD;
          -  Subjects who must use oral corticosteroids and/or oral immunosuppressive drugs&#xD;
             (steroid inhalers or decongestant nose drops and/or eye drops are permitted).&#xD;
&#xD;
          -  Any condition for which the Investigator determines that the subject could be placed&#xD;
             under undo risk.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>13 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michelle T Pelle, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical Director</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>MedDerm Associates</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://medderm.net</url>
    <description>Related Info</description>
  </link>
  <verification_date>June 2014</verification_date>
  <study_first_submitted>March 1, 2007</study_first_submitted>
  <study_first_submitted_qc>June 3, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 4, 2009</study_first_posted>
  <last_update_submitted>June 23, 2014</last_update_submitted>
  <last_update_submitted_qc>June 23, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 24, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>MedDerm Associates</investigator_affiliation>
    <investigator_full_name>Michelle Pelle, M.D.</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Acne</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acne Vulgaris</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

